Keyphrases
Primary Tumor
100%
Microenvironment
100%
Tumor Microenvironment
100%
Breast Cancer Liver Metastases
100%
Machine Learning Analysis
100%
Metastasis Tumor Microenvironment
30%
Matrix metalloproteinase-9 (MMP-9)
20%
Immunotherapeutic Strategy
20%
Programmed Death-ligand 1 (PD-L1)
20%
CD163
20%
Primary Breast Tumor
20%
CD206
20%
Macrophages
10%
Monocytes
10%
Immune Response
10%
CD14
10%
Extracellular Matrix
10%
Tumor Samples
10%
Resection
10%
Collagen
10%
Confidence Interval
10%
α-smooth muscle Actin (α-SMA)
10%
Ki-67
10%
Possible Complications
10%
CD31
10%
ERK Phosphorylation
10%
CD68
10%
Hypoxia
10%
Histological Analysis
10%
Cell Adhesion
10%
Human Breast Cancer
10%
CD56
10%
Hypoxia-inducible factor-1α (HIF-1α)
10%
E-cadherin
10%
Tumor Tissue
10%
Vascular Function
10%
Median Value
10%
Primary Tumor Tissue
10%
Breast Cancer Classification
10%
CD68+
10%
Tumor-associated Macrophages
10%
Cluster Density
10%
Hypovascular
10%
Marker Cluster
10%
Area under the Receiver Operating Characteristic (AUROC)
10%
E-cad
10%
Marker Data
10%
Robust Classification
10%
Imaging Mass Cytometry
10%
Machine Learning Workflow
10%
Metastasis Marker
10%
Tumor Cluster
10%
Tumor Marker Index
10%
Immunology and Microbiology
CD68
100%
CD163
100%
Immune Response
50%
Macrophage
50%
CD14
50%
Tumor-Associated Macrophage
50%
Actin
50%
CD4
50%
Hypoxia Inducible Factor 1
50%
Vascularization
50%
Cadherin
50%
Extracellular Matrix
50%
Smooth Muscle
50%
Cell Adhesion
50%
CD31
50%
Programmed Death 1 Receptor
50%
Programmed Death-Ligand 1
50%
Mass Cytometry
50%
Medicine and Dentistry
Breast Cancer
100%
Primary Tumor
100%
Liver Metastasis
100%
Tumor Microenvironment
100%
Neoplasm
18%
Macrophage
18%
Chlordane
18%
Breast Tumor
18%
Gelatinase B
18%
Biopsy Technique
9%
Surgery
9%
Immune Response
9%
Vascularity
9%
Hypoxia
9%
Extracellular Matrix
9%
Tumor Marker
9%
Uvomorulin
9%
Cell Adhesion
9%
Hypoxia Inducible Factor 1
9%
Programmed Death-Ligand 1
9%
Programmed Death 1 Receptor
9%
Alpha Smooth Muscle Actin
9%
Mass Cytometry
9%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Liver Metastasis
100%
Primary Tumor
100%
Tumor Microenvironment
100%
Neoplasm
18%
Gelatinase B
18%
Breast Tumor
18%
Chlordane
18%
Uvomorulin
9%
Tumor Marker
9%
Hypoxia
9%
Alpha Smooth Muscle Actin
9%
Hypoxia Inducible Factor 1
9%
Programmed Death 1 Receptor
9%